EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study

Henk-Jan Guchelaar iD, Cathelijne H van der Wouden, Lisanne E N Manson, Heshu Abdullah-Koolmees iD, Kathrin Blagec, Tanja Blagus, Stefan Böhringer, Erika Cecchin iD, Ka-Chun Cheung, Vera H M Deneer, Siv Jonsson, Candace Joefield-Roka und 26 weitere

Clinical Pharmacology & Therapeutics · 2025-10 · 118 (4) · 803-812

DOI: 10.1002/cpt.3749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 24.06.2025. Verfasst von Henk-Jan Guchelaar und 37 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Pharmacogenomic Testing, Drug-Related Side Effects and Adverse Reactions, Pharmacogenetics. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Union, Horizon 2020 Research and Innovation Program, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Ubiquitous Pharmacogenomics consortium ( www.upgx.eu ) has recently completed and published the Preemptive Pharmacogenomic Testing for Preventing Adverse Drug Reactions (PREPARE) study on the implementation of panel‐based pharmacogenetic testing. PREPARE has provided interesting lessons for the design, execution, and interpretation of future clinical implementation studies. In this paper, we share our experience and lessons learned from the PREPARE study for future pharmacogenetic implementation studies. Issues addressed are the study population, intervention, endpoint, randomization, blinding, crossover, ethics, real‐world changes during the study, and data analysis and reporting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pharmacogenomic TestingDrug-Related Side Effects and Adverse ReactionsPharmacogeneticsHumansResearch DesignCross-Over Studies

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Hospital Pharmacy, Amsterdam University Medical Center, Amsterdam, The Netherlands.
  • Institute of Artificial Intelligence, Centre for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.
  • Pharmacogenetics Laboratory, Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
  • Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
  • Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.

ORCID-Profile: Henk-Jan Guchelaar, Heshu Abdullah-Koolmees, Erika Cecchin, Katja S Just, Mats O Karlsson, Rudolf Koopmann, Thorsten Lehr, Rossana Roncato, Matthias Schwab, Julia C Stingl, Roman Tremmel, Munir Pirmohamed, Gere Sunder-Plassmann, Giuseppe Toffoli, Jesse J Swen

Förderung

  • European Union, Horizon 2020 Research and Innovation Program
  • European Commission

Zitieren

APA

Guchelaar, H. J., van der Wouden, C. H., Manson, L. E. N., Abdullah-Koolmees, H., Blagec, K., Blagus, T., Böhringer, S., Cecchin, E., Cheung, K. C., Deneer, V. H. M., Jonsson, S., Joefield-Roka, C., Just, K. S., Karlsson, M. O., Konta, L., Koopmann, R., Kriek, M., Lehr, T., Mitropoulou, C., …, & Ubiquitous Pharmacogenomics Consortium (2025). Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study. Clinical Pharmacology & Therapeutics, 118(4), 803-812. https://doi.org/10.1002/cpt.3749

Vancouver

Guchelaar HJ, van der Wouden CH, Manson LEN, Abdullah-Koolmees H, Blagec K, Blagus T, et al. Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study. Clinical Pharmacology & Therapeutics. 2025;118(4):803-812. doi:10.1002/cpt.3749

BibTeX
@article{Guchelaar2025,
  author = {Guchelaar, Henk-Jan and van der Wouden, Cathelijne H and Manson, Lisanne E N and Abdullah-Koolmees, Heshu and Blagec, Kathrin and Blagus, Tanja and Böhringer, Stefan and Cecchin, Erika and Cheung, Ka-Chun and Deneer, Vera H M and Jonsson, Siv and Joefield-Roka, Candace and Just, Katja S and Karlsson, Mats O and Konta, Lidija and Koopmann, Rudolf and Kriek, Marjolein and Lehr, Thorsten and Mitropoulou, Christina and Rollinson, Victoria and Roncato, Rossana and Samwald, Matthias and Schaeffeler, Elke and Skokou, Maria and Schwab, Matthias and Steinberger, Daniela and Stingl, Julia C and Tremmel, Roman and Turner, Richard M and van Rhenen, Mandy H and Dávila-Fajardo, Cristina L and Dolžan, Vita and Patrinos, George P and Pirmohamed, Munir and Sunder-Plassmann, Gere and Toffoli, Giuseppe and Swen, Jesse J and Ubiquitous Pharmacogenomics Consortium, Ubiquitous Pharmacogenomics Consortium},
  title = {Pharmacogenetic Implementation Studies—Lessons Learned From the PREPARE Study},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2025},
  volume = {118},
  number = {4},
  pages = {803--812},
  doi = {10.1002/cpt.3749}
}
Kostenlos starten →